Hot Investor Mandate: China Healthcare Company Invests in Novel Therapeutics Across Oncology, CNS, Infectious Disease, and More Throughout USA, Europe, and China

31 Jan

A healthcare company in China headquartered in Shanghai, China focuses on patent licensing, technology acquisition, joint development, etc. The firm seeks new technologies and projects across Greater China, the US, and some European countries.

In the life sciences, the firm is currently looking for innovative therapeutics companies. The firm will focus on assets in five indication areas: oncology, CNS, cardiovascular, metabolic disease and nutritional, and infectious diseases. For the type of modality, the firm is open to companies developing small molecule, biologics, gene therapy and cell therapy. The firm is most interested in products in clinical phase II and phase III stage, but will consider earlier stage companies that show promising technologies.

The firm is interested in privately held life science companies with experienced management teams and innovative technologies.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: